Viewing Study NCT03054532

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:54 PM

Ignite Modification Date: 2025-12-28 @ 5:07 AM

Study NCT ID: NCT03054532

Status: UNKNOWN

Last Update Posted: 2017-02-16

First Post: 2017-02-13

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma

Sponsor: Singapore General Hospital

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module